EUVIMEDEUVIMED entdecken
Crossref

Long-read sequencing for NF1 gene analysis: enhancing diagnostic accuracy for Neurofibromatosis type 1

Yu Zheng, Miaomiao Chen, Shuju Zhang, Yu Peng, Xinghan Wu, Danni Guo, Yaoxi Liu, Aiping Mao, Danhua Li, Tiantian Xie, Haibo Mei, Guanghui Zhu und 1 weitere

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Yu Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South Universit…. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neurofibromin 1, Genes, Neurofibromatosis 1. Die Arbeit nennt 41 Literaturangaben. Gefördert von: the special fund of Hunan Provincial Key Laboratory of Pediatric Orthopedics, the Clinical Medical Research Center for Hereditary Birth Defects and Rare Diseases in Hunan Province, Hunan Province Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Clinical diagnosis of Neurofibromatosis type 1 (NF1) in pediatric patients is challenged by incomplete manifestation of age-dependent phenotypes, and molecular genetic testing is usually required to confirm the diagnosis. Early differential diagnosis is particularly crucial for children presenting solely with multiple Cafe-au-lait spots (CALMs). Here we developed a comprehensive analysis of the NF1 gene (CANF1) based on long-range PCR and long-read sequencing (LRS) for genetic testing of NF1. This blinded retrospective study evaluated the clinical utility of CANF1 in 191 samples from 189 individuals (180 probands, 9 NF1 family members) by comparing it to next-generation sequencing (NGS), primarily exome sequencing (ES), as control methods. The results demonstrated concordant findings in 97.4% (186/191) of samples and 97.2% (175/180) of probands, and discordant results in 2.6% (5/191) of samples and 2.8% (5/180) of probands, including one newly established diagnosis due to a patient harboring the pathogenic deep intronic variant c.5812 + 332A > G. Among 126 pediatric probands with NF1, this assay achieved a diagnostic yield of 92.1%, outperforming ES with cost-competitive advantages. In conclusion, this study established an NF1 genetic assay employing LRS, demonstrating reliable detection for various variant types of the NF1 gene. The CANF1 assay provides an alternative screening approach for precise and cost-effective NF1 diagnosis, particularly valuable for pediatric cases not fulfilling NF1 clinical diagnostic criteria but presenting with a characteristic NF1 feature such as CALMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1Neurofibromin 1Genes, Neurofibromatosis 1HumansFemaleChildMaleHigh-Throughput Nucleotide SequencingGenetic TestingChild, PreschoolAdolescentInfantRetrospective StudiesMutationSequence Analysis, DNA

Stichwörter der Autor:innen

Café au lait maculeNF1Neurofibromatosis 1genetic testinglong-read sequencing

Substanzen

Neurofibromin 1NF1 protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, No. 86 Ziyuan Road, Yuhua District, 410007, Changsha, Hunan, and Cl…
  • Department of Pediatric Orthopedics, Hunan Provincial Key Laboratory of Pediatric Orthopedics, The Affiliated Children's Hospital of Xiangya School of Medicine (Hunan Children's Hospital), Central South University, and…
  • Department of Research and Development, Berry Genomics Corporation, No. 4 Courtyard, Shengmingyuan Road, Changping District Science Park, 102206, Beijing, China.

Förderung

  • the special fund of Hunan Provincial Key Laboratory of Pediatric Orthopedics
  • the Clinical Medical Research Center for Hereditary Birth Defects and Rare Diseases in Hunan Province
  • Hunan Province Natural Science Foundation of China

Zitieren

APA

Zheng, Y., Chen, M., Zhang, S., Peng, Y., Wu, X., Guo, D., Liu, Y., Mao, A., Li, D., Xie, T., Mei, H., Zhu, G., & Wang, H. (2025). Long-read sequencing for NF1 gene analysis: enhancing diagnostic accuracy for Neurofibromatosis type 1. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf108

Vancouver

Zheng Y, Chen M, Zhang S, Peng Y, Wu X, Guo D, et al. Long-read sequencing for NF1 gene analysis: enhancing diagnostic accuracy for Neurofibromatosis type 1. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf108

BibTeX
@article{Zheng2025,
  author = {Zheng, Yu and Chen, Miaomiao and Zhang, Shuju and Peng, Yu and Wu, Xinghan and Guo, Danni and Liu, Yaoxi and Mao, Aiping and Li, Danhua and Xie, Tiantian and Mei, Haibo and Zhu, Guanghui and Wang, Hua},
  title = {Long-read sequencing for NF1 gene analysis: enhancing diagnostic accuracy for Neurofibromatosis type 1},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf108}
}
Kostenlos starten →